DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis Denise BernhardtLaila KönigExpert Panel of the German Society of Radiation Oncology (DEGRO) Review Article Open access 29 August 2022 Pages: 873 - 883
Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapy Martin SalzmannKlaus HessJessica C. Hassel Original Article Open access 11 May 2022 Pages: 884 - 891
Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy R. DumkeC. DumkeS. Lautenschläger Original Article Open access 25 May 2022 Pages: 892 - 906
Evaluation of the ability of the Brainlab Elements Cranial Distortion Correction algorithm to correct clinically relevant MRI distortions for cranial SRT Paul RetifAbdourahamane Djibo SidikouXavier Michel Original Article 18 August 2022 Pages: 907 - 918
Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO) S. RogersB. BaumertS. E. Combs Short Communication 25 August 2022 Pages: 919 - 925
Stereotactic radiotherapy of brain metastases: clinical impact of three-dimensional SPACE imaging for 3T-MRI-based treatment planning Thomas WelzelRami A. El ShafieJürgen Debus Original Article Open access 17 August 2022 Pages: 926 - 933
Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factors Francesco CucciaRosario MazzolaFilippo Alongi Original Article 02 May 2022 Pages: 934 - 939
Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study Cem OnalOzan Cem GulerGokhan Ozyigit Original Article 13 June 2022 Pages: 940 - 948
Antiemetic prophylaxis for chemoradiotherapy-induced nausea and vomiting in locally advanced head and neck squamous cell carcinoma: a prospective phase II trial Zekun WangWenyang LiuYe Zhang Original Article 30 May 2022 Pages: 949 - 957
Correction to: Comparison of 3D and 4D Monte Carlo optimization in robotic tracking stereotactic body radiotherapy of lung cancer Mark K. H. ChanRene WernerOliver Blanck Correction Open access 27 June 2022 Pages: 958 - 958
Risikostandardisierte Mortalitätsraten übertreffen als Qualitätsindikator die typischen „Mindestzahlen“ in der onkologischen Chirurgie – ein neuer Blick auf Krankenhauszentralisationen mithilfe nationaler bevölkerungsbezogener Daten Zsolt SziklavariG. G. Grabenbauer Literatur kommentiert Open access 01 July 2022 Pages: 959 - 961
Multimodale Therapieansätze beim Hochrisikoprostatakarzinom – was wann? Etienne MathierAstrid HeuselMohamed Shelan Literatur kommentiert 22 June 2022 Pages: 962 - 965
Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie Alexander RühleNils H. Nicolay Literatur kommentiert Open access 20 June 2022 Pages: 966 - 969